摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-Bromo-2-isopropyl-1,6-dimethoxynaphthalene | 146356-61-8

中文名称
——
中文别名
——
英文名称
4-Bromo-2-isopropyl-1,6-dimethoxynaphthalene
英文别名
4-Bromo-1,6-dimethoxy-2-propan-2-ylnaphthalene
4-Bromo-2-isopropyl-1,6-dimethoxynaphthalene化学式
CAS
146356-61-8
化学式
C15H17BrO2
mdl
——
分子量
309.203
InChiKey
HPFGFSRSFPBJDA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.9
  • 重原子数:
    18
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    18.5
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Synthetic studies on diterpenoid quinones with interleukin-1 inhibitory activity. Total synthesis of (.+-.)- and (+)-triptoquinone A
    摘要:
    An efficient first total synthesis of (+/-)- and (+)-triptoquinone A (1), a novel diterpenoid quinone with significant inhibitory activity against interleukin-1 releases, has been completed. Birch reduction of tricyclic enone (+/-)-7, prepared from known 6-methoxy-2-isopropyl-1-naphthol (22), which is readily available in large quantities, was followed by immediate enolate trapping to provide silyl enol ether (+/-)-30. Compound 30 was converted into carboxylic acid (+/-)-4 via the corresponding enol triflate (+/-)-31 either by sequential palladium-catalyzed carbonylation and oxidation or by direct carboxylation. The total synthesis of (+/-)-1 was completed by oxidation of (+/-)-4 with CAN in 12 steps from 22 in 19% overall yield at best. A second, enantioselective total synthesis of (+)-1 was accomplished via (+/-)-7, which was prepared by (-)-N- [4-(trifluoromethyl)benzyl]cinchonidinium bromide (33) catalyzed asymmetric Michael reaction of 6 with ethyl vinyl ketone and a subsequent aldol condensation. The absolute structures of triptoquinone B (2) and C (3), which were isolated concomitantly with triptoquinone A from the same plant sources, were established by a series of chemical reactions based on (+)-7.
    DOI:
    10.1021/jo00081a021
  • 作为产物:
    参考文献:
    名称:
    Synthetic studies on diterpenoid quinones with interleukin-1 inhibitory activity. Total synthesis of (.+-.)- and (+)-triptoquinone A
    摘要:
    An efficient first total synthesis of (+/-)- and (+)-triptoquinone A (1), a novel diterpenoid quinone with significant inhibitory activity against interleukin-1 releases, has been completed. Birch reduction of tricyclic enone (+/-)-7, prepared from known 6-methoxy-2-isopropyl-1-naphthol (22), which is readily available in large quantities, was followed by immediate enolate trapping to provide silyl enol ether (+/-)-30. Compound 30 was converted into carboxylic acid (+/-)-4 via the corresponding enol triflate (+/-)-31 either by sequential palladium-catalyzed carbonylation and oxidation or by direct carboxylation. The total synthesis of (+/-)-1 was completed by oxidation of (+/-)-4 with CAN in 12 steps from 22 in 19% overall yield at best. A second, enantioselective total synthesis of (+)-1 was accomplished via (+/-)-7, which was prepared by (-)-N- [4-(trifluoromethyl)benzyl]cinchonidinium bromide (33) catalyzed asymmetric Michael reaction of 6 with ethyl vinyl ketone and a subsequent aldol condensation. The absolute structures of triptoquinone B (2) and C (3), which were isolated concomitantly with triptoquinone A from the same plant sources, were established by a series of chemical reactions based on (+)-7.
    DOI:
    10.1021/jo00081a021
点击查看最新优质反应信息

文献信息

  • NITROGEN MONOXIDE SYNTHESIS INHIBITOR
    申请人:OTSUKA PHARMACEUTICAL CO., LTD.
    公开号:EP0676196A1
    公开(公告)日:1995-10-11
    A nitrogen monoxide synthesis inhibitor containing as the active ingredient at least one member selected from phenanthrene derivatives represented by the compounds of general formula (1) and salts thereof; it is useful for preventing and treating various diseases caused by nitrogen monoxide, such as endotoxin shock.
    一种一氧化氮合成抑制剂,含有至少一种选自通式(1)化合物所代表的菲衍生物及其盐类的活性成分;可用于预防和治疗一氧化氮引起的各种疾病,如内毒素休克。
  • Total synthesis of (±)-triptoquinone A
    作者:Kozo Shishido、Kiyoto Goto、Shizuka Miyoshi、Yoshihisa Takaishi、Masayuki Shibuya
    DOI:10.1016/s0040-4039(00)60582-8
    日期:1993.1
    A concise and practical total synthesis of (+/-)-triptoquinone A (1), a novel interleukin-1 inhibitor isolated from Tripterygium wilfordii var. regelii, has been achieved in 11 steps from the known naphthol 2.
  • US5654343A
    申请人:——
    公开号:US5654343A
    公开(公告)日:1997-08-05
  • Synthetic studies on diterpenoid quinones with interleukin-1 inhibitory activity. Total synthesis of (.+-.)- and (+)-triptoquinone A
    作者:Kozo Shishido、Kiyoto Goto、Shizuka Miyoshi、Yoshihisa Takaishi、Masayuki Shibuya
    DOI:10.1021/jo00081a021
    日期:1994.1
    An efficient first total synthesis of (+/-)- and (+)-triptoquinone A (1), a novel diterpenoid quinone with significant inhibitory activity against interleukin-1 releases, has been completed. Birch reduction of tricyclic enone (+/-)-7, prepared from known 6-methoxy-2-isopropyl-1-naphthol (22), which is readily available in large quantities, was followed by immediate enolate trapping to provide silyl enol ether (+/-)-30. Compound 30 was converted into carboxylic acid (+/-)-4 via the corresponding enol triflate (+/-)-31 either by sequential palladium-catalyzed carbonylation and oxidation or by direct carboxylation. The total synthesis of (+/-)-1 was completed by oxidation of (+/-)-4 with CAN in 12 steps from 22 in 19% overall yield at best. A second, enantioselective total synthesis of (+)-1 was accomplished via (+/-)-7, which was prepared by (-)-N- [4-(trifluoromethyl)benzyl]cinchonidinium bromide (33) catalyzed asymmetric Michael reaction of 6 with ethyl vinyl ketone and a subsequent aldol condensation. The absolute structures of triptoquinone B (2) and C (3), which were isolated concomitantly with triptoquinone A from the same plant sources, were established by a series of chemical reactions based on (+)-7.
查看更多